RxDoctor Payments Data

Douglas Adler, MD

Gastroenterology · Colorado Springs, CONPI 1891748687

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $581,202 of the $910,161 with a category attached, or 63.9%. 27 manufacturers reported payments, led by AbbVie at 55.4% of the total. Reporting peaked in 2021 at $198,119 and has fallen 61.8% since, to $75,711 in 2025. Among gastroenterology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$910,161in general payments, 2019–2025

Across 792 payments — averaging $1149.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$504K
  • Boston Scientific$139K
  • Olympus Corporation$56K
  • Olympus America Inc.$50K
  • Merit Medical Systems Inc$45K
  • Olympus Corporation Of The Americas$30K
  • plus $86K from 21 others
$257,661in research payments, 2019–2025

Across 16 payments — averaging $16,104 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Olympus Corporation Of The Americas$138K
  • Cook Research Incorporated$98K
  • Boston Scientific$19K
  • Medtronic$2K

What the payments were for

  • Consulting fees$237,51526%
  • Speaking & faculty fees$581,20264%
  • Travel & lodging$78,5919%
  • Food & beverage$12,8181%
  • Education$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$910,161 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado

Medicare billing

Part B allowed, 2024
$148,708
Medicare patients
248
Services billed
804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ursodiol12$1,448
Levofloxacin135$390
Omeprazole15$212
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$104

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →